Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Guardian Pharmacy Services, Inc. (GRDN)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: GRDN (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
3 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $24.33
1 Year Target Price $24.33
| 2 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -4.07% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.25B USD | Price to earnings Ratio - | 1Y Target Price 24.33 |
Price to earnings Ratio - | 1Y Target Price 24.33 | ||
Volume (30-day avg) 3 | Beta - | 52 Weeks Range 14.16 - 26.91 | Updated Date 05/24/2025 |
52 Weeks Range 14.16 - 26.91 | Updated Date 05/24/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.38 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -7.45% | Operating Margin (TTM) -33.28% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 1287743082 | Price to Sales(TTM) 1.07 |
Enterprise Value 1287743082 | Price to Sales(TTM) 1.07 | ||
Enterprise Value to Revenue 1.1 | Enterprise Value to EBITDA - | Shares Outstanding 9200000 | Shares Floating 9142852 |
Shares Outstanding 9200000 | Shares Floating 9142852 | ||
Percent Insiders 0.96 | Percent Institutions 104.3 |
Analyst Ratings
Rating 2 | Target Price 24.33 | Buy 1 | Strong Buy 2 |
Buy 1 | Strong Buy 2 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Guardian Pharmacy Services, Inc.
Company Overview
History and Background
Guardian Pharmacy Services was founded in 2004 to serve the unique needs of the long-term care pharmacy market. It has grown through acquisitions and organic growth, focusing on providing specialized pharmacy services to assisted living, skilled nursing, and other long-term care facilities.
Core Business Areas
- Long-Term Care Pharmacy Services: Providing medication dispensing, clinical consulting, and specialized packaging to long-term care facilities.
- Specialty Pharmacy Services: Offering services tailored to patients with complex or chronic conditions, often requiring specialized medications and monitoring.
- Pharmacy Benefit Management (PBM): Helping facilities manage their pharmacy costs and ensure medication adherence.
Leadership and Structure
The company has a leadership team comprising experienced pharmacy executives and regional directors. The organizational structure is decentralized, with individual pharmacies operating with local autonomy while adhering to Guardian's standards and best practices. Guardian is backed by a private equity firm.
Top Products and Market Share
Key Offerings
- Clinical Consulting Services: Pharmacist-led medication reviews, drug utilization evaluations, and other clinical services to optimize medication therapy for residents. Competitors include Omnicare, PharMerica, and independent pharmacy consultants. Market share data is difficult to obtain as Guardian is private and market share reporting is incomplete.
- Medication Dispensing & Delivery: Provision of prescription and over-the-counter medications in various formats (unit-dose, multi-dose packaging) to long-term care facilities. Competitors include Omnicare, PharMerica, and other regional LTC pharmacies. Market share data is difficult to obtain as Guardian is private and market share reporting is incomplete. They are estimated to be in the top 5 in market share.
- Specialty Pharmacy Medications: Distribution of specialty drugs for conditions like HIV, hepatitis, and cancer to patients in long-term care or assisted living facilities. Competitors include Accredo, CVS Specialty, and other national specialty pharmacies. Market share data is difficult to obtain as Guardian is private and market share reporting is incomplete.
Market Dynamics
Industry Overview
The long-term care pharmacy market is driven by an aging population, increasing prevalence of chronic diseases, and growing demand for specialized pharmacy services in long-term care facilities. The industry is also subject to regulatory changes and reimbursement pressures.
Positioning
Guardian Pharmacy Services is positioned as a leading provider of long-term care pharmacy services, with a focus on personalized service, clinical expertise, and technology-enabled solutions. Its competitive advantages include its decentralized model, strong relationships with long-term care facilities, and commitment to quality and compliance.
Total Addressable Market (TAM)
The U.S. long-term care pharmacy market is estimated to be around $30-40 billion annually. Guardian Pharmacy Services is positioned to capture a significant share of this market through its specialized services and geographic expansion.
Upturn SWOT Analysis
Strengths
- Strong relationships with long-term care facilities
- Decentralized operating model
- Commitment to quality and compliance
- Experienced management team
- Specialized clinical expertise
Weaknesses
- Limited brand recognition compared to larger national chains
- Exposure to reimbursement pressures and regulatory changes
- Reliance on acquisitions for growth
- Higher prices
Opportunities
- Expanding into new geographic markets
- Developing new specialized pharmacy services
- Leveraging technology to improve efficiency and patient outcomes
- Partnering with healthcare providers and payers
- Growing demand in speciality pharmacy
Threats
- Increased competition from national pharmacy chains
- Consolidation in the long-term care industry
- Changes in government regulations and reimbursement policies
- Economic downturn impacting long-term care occupancy rates
- Drug shortages
Competitors and Market Share
Key Competitors
- OMN
- WBA
- CVS
Competitive Landscape
Guardian Pharmacy Services competes with large national pharmacy chains like Omnicare and CVS, as well as regional and independent long-term care pharmacies. Guardian differentiates itself through its personalized service, clinical expertise, and technology-enabled solutions. Omnicare and CVS have greater brand recognition and resources but may not offer the same level of personalized service.
Major Acquisitions
Various regional and local long-term care pharmacies
- Year: 2022
- Acquisition Price (USD millions):
- Strategic Rationale: Expansion of geographic footprint, increase in patient base, and access to new technologies and expertise.
Growth Trajectory and Initiatives
Historical Growth: Guardian Pharmacy Services has grown rapidly through acquisitions and organic growth, expanding its geographic footprint and service offerings.
Future Projections: Future growth is expected to be driven by the aging population, increasing demand for long-term care services, and the company's ability to expand into new markets and offer innovative solutions.
Recent Initiatives: Recent initiatives may include acquiring smaller regional pharmacies, investing in technology to improve medication management, and expanding its specialty pharmacy services.
Summary
Guardian Pharmacy Services is a growing company in the long-term care pharmacy market. Its strengths lie in its decentralized model, strong relationships, and clinical expertise. It faces competition from larger national chains and reimbursement pressures, but its focus on personalized service and innovation positions it for future growth. It needs to carefully manage its acquisition strategy and adapt to evolving regulatory landscape to maintain its competitive edge.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Market Research Reports
- Press Releases
- Publicly available competitor information
Disclaimers:
Financial data for Guardian Pharmacy Services is based on estimates and industry averages due to its private status. Market share data is also based on approximations. This analysis is for informational purposes only and should not be considered financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Guardian Pharmacy Services, Inc.
Exchange NYSE | Headquaters Atlanta, GA, United States | ||
IPO Launch date 2024-09-26 | CEO, President & Director Mr. Fred P. Burke | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 3400 | Website https://guardianpharmacy.com |
Full time employees 3400 | Website https://guardianpharmacy.com | ||
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.